These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34381355)

  • 1. The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells.
    Wang Y; Shen H; Sun Q; Zhao L; Liu H; Ye L; Xu Y; Cai J; Li Y; Gao L; Tan Y; Liu B; Chen Q
    Front Pharmacol; 2021; 12():659511. PubMed ID: 34381355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway.
    Gao L; Liu J; Xu P; Deng G; Liu B; Yuan F; Tan Y; Sun Q; Xu Y; Zhang H; Qi Y; Han S; Yang K; Geng R; Jiang H; Chen Q
    Front Pharmacol; 2020; 11():1102. PubMed ID: 32848734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PI3K pathway in the brain--efficacy of a PI3K inhibitor optimized to cross the blood-brain barrier.
    Salphati L; Heffron TP; Alicke B; Nishimura M; Barck K; Carano RA; Cheong J; Edgar KA; Greve J; Kharbanda S; Koeppen H; Lau S; Lee LB; Pang J; Plise EG; Pokorny JL; Reslan HB; Sarkaria JN; Wallin JJ; Zhang X; Gould SE; Olivero AG; Phillips HS
    Clin Cancer Res; 2012 Nov; 18(22):6239-48. PubMed ID: 22992516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
    Ye X; Ruan JW; Huang H; Huang WP; Zhang Y; Zhang F
    Aging (Albany NY); 2020 May; 12(10):9489-9499. PubMed ID: 32421688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway.
    Zheng X; Li W; Xu H; Liu J; Ren L; Yang Y; Li S; Wang J; Ji T; Du G
    Acta Pharm Sin B; 2021 Nov; 11(11):3465-3480. PubMed ID: 34900530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway.
    Xing S; Xiong Z; Wang M; Li Y; Shi J; Qian Y; Lei J; Jia J; Zeng W; Huang Z; Jiang Y
    Am J Cancer Res; 2024; 14(8):3757-3772. PubMed ID: 39267674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway.
    Xing J; Li Y; Zhao H
    Oncol Lett; 2021 May; 21(5):387. PubMed ID: 33777210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms.
    Jin L; Zhang W; Yao MY; Tian Y; Xue BX; Tao W
    Cell Death Discov; 2022 Mar; 8(1):120. PubMed ID: 35296639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daphnoretin inhibits glioblastoma cell proliferation and metastasis via PI3K/AKT signaling pathway inactivation.
    Lei J; Zhou H; Cheng S; Yu W; Yang M; Lin L
    J Cancer; 2024; 15(17):5810-5827. PubMed ID: 39308674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway.
    Zhang W; Gong P; Tian Q; Han S; Wang J; He P; Guo Y; Wang G; Chen Q; Huang J; Li M
    J Oncol; 2022; 2022():4396316. PubMed ID: 35677890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin inhibits the proliferation, migration and invasion, but promotes the apoptosis of U251 and U87 cells via the PI3K/AKT/mTOR signaling pathway.
    Zhang J; Fan J
    Exp Ther Med; 2020 Aug; 20(2):1145-1152. PubMed ID: 32765662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.